ASBP
Price
$7.09
Change
+$1.02 (+16.80%)
Updated
Jul 27, 04:59 PM (EDT)
Capitalization
N/A
Intraday BUY SELL Signals
SLXN
Price
$2.53
Change
+$0.26 (+11.45%)
Updated
Jul 27 closing price
Capitalization
2.69M
21 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ASBP vs SLXN

ASBP vs SLXN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ASBP vs. SLXN commentary
Jul 28, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASBP is a Buy and SLXN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2026
Stock price -- (ASBP: $6.01 vs. SLXN: $2.53)
Brand notoriety: ASBP and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASBP: 6% vs. SLXN: 13%
Market capitalization -- ASBP: $0 vs. SLXN: $2.69M
ASBP [@Biotechnology] is valued at $0. SLXN’s [@Biotechnology] market capitalization is $2.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.57B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASBP’s FA Score shows that 1 FA rating(s) are green whileSLXN’s FA Score has 0 green FA rating(s).

  • ASBP’s FA Score: 1 green, 4 red.
  • SLXN’s FA Score: 0 green, 5 red.
According to our system of comparison, ASBP is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASBP’s TA Score shows that 6 TA indicator(s) are bullish while SLXN’s TA Score has 6 bullish TA indicator(s).

  • ASBP’s TA Score: 6 bullish, 0 bearish.
  • SLXN’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, ASBP is a better buy in the short-term than SLXN.

Price Growth

ASBP (@Biotechnology) experienced а 0.00% price change this week, while SLXN (@Biotechnology) price change was -4.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.94%. For the same industry, the average monthly price growth was -4.26%, and the average quarterly price growth was +1936.60%.

Reported Earning Dates

SLXN is expected to report earnings on Aug 18, 2026.

Industries' Descriptions

@Biotechnology (-1.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLXN YTD gains are higher at: -86.823 vs. ASBP (-96.203).
ASBPSLXNASBP / SLXN
CapitalizationN/A2.69M-
EBITDAN/A-12.91M-
Gain YTD-96.203-86.823111%
P/E RatioN/A0.00-
RevenueN/A0-
Total CashN/A2.41M-
Total DebtN/A1.99M-
TECHNICAL ANALYSIS
Technical Analysis
ASBPSLXN
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
63%
Bullish Trend 1 day ago
40%
Momentum
ODDS (%)
Bullish Trend 4 days ago
46%
Bullish Trend 1 day ago
36%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
41%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
43%
Bearish Trend 1 day ago
65%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
61%
Bearish Trend 1 day ago
76%
Advances
ODDS (%)
N/A
Bullish Trend 12 days ago
55%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 1 day ago
61%
Aroon
ODDS (%)
Bullish Trend 4 days ago
33%
Bearish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ASBP
Daily Signal:
Gain/Loss:
SLXN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VVX87.313.74
+4.48%
V2X
TMQ3.100.08
+2.65%
Trilogy Metals
NWS30.920.73
+2.42%
News Corp
CSPI8.000.05
+0.63%
CSP
CMND1.620.01
+0.62%
Clearmind Medicine Inc.

ASBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASBP has been loosely correlated with SPRO. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ASBP jumps, then SPRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASBP
1D Price
Change %
ASBP100%
N/A
SPRO - ASBP
42%
Loosely correlated
-0.84%
ALZN - ASBP
38%
Loosely correlated
+0.75%
DCOY - ASBP
31%
Poorly correlated
-25.79%
CMPX - ASBP
28%
Poorly correlated
+0.48%
GRCE - ASBP
27%
Poorly correlated
-1.29%
More